Neuroprotective amyloid β N-terminal peptides differentially alter human α7- and α7β2-nicotinic acetylcholine (nACh) receptor single-channel properties
- PMID: 38720171
- DOI: 10.1111/bph.16381
Neuroprotective amyloid β N-terminal peptides differentially alter human α7- and α7β2-nicotinic acetylcholine (nACh) receptor single-channel properties
Abstract
Background and purpose: Oligomeric amyloid β 1-42 (oAβ1-42) exhibits agonist-like action at human α7- and α7β2-containing nicotinic receptors. The N-terminal amyloid β1-15 fragment (N-Aβ fragment) modulates presynaptic calcium and enhances hippocampal-based synaptic plasticity via α7-containing nicotinic receptors. Further, the N-Aβ fragment and its core sequence, the N-amyloid-beta core hexapeptide (N-Aβcore), protect against oAβ1-42-associated synapto- and neurotoxicity. Here, we investigated how oAβ1-42, the N-Aβ fragment, and the N-Aβcore regulate the single-channel properties of α7- and α7β2-nicotinic receptors.
Experimental approach: Single-channel recordings measured the impact of acetylcholine, oAβ1-42, the N-Aβ fragment, and the N-Aβcore on the unitary properties of human α7- and α7β2-containing nicotinic receptors expressed in nicotinic-null SH-EP1 cells. Molecular dynamics simulations identified potential sites of interaction between the N-Aβ fragment and orthosteric α7+/α7- and α7+/β2- nicotinic receptor binding interfaces.
Key results: The N-Aβ fragment and N-Aβcore induced α7- and α7β2-nicotinic receptor single-channel openings. Relative to acetylcholine, oAβ1-42 preferentially enhanced α7β2-nicotinic receptor single-channel open probability and open-dwell times. Co-application with the N-Aβcore neutralized these effects. Further, administration of the N-Aβ fragment alone, or in combination with acetylcholine or oAβ1-42, selectively enhanced α7-nicotinic receptor open probability and open-dwell times (compared to acetylcholine or oAβ1-42).
Conclusions and implications: Amyloid-beta peptides demonstrate functional diversity in regulating α7- and α7β2-nicotinic receptor function, with implications for a wide range of nicotinic receptor-mediated functions in Alzheimer's disease. The effects of these peptides on α7- and/or α7β2-nicotinic receptors revealed complex interactions with these subtypes, providing novel insights into the neuroprotective actions of amyloid β-derived fragments against the toxic effects of oAβ1-42.
Keywords: Alzheimer's disease; amyloid; concatemers; nicotinic receptors; single‐channel.
© 2024 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.
Similar articles
-
Functional α7β2 nicotinic acetylcholine receptors expressed in hippocampal interneurons exhibit high sensitivity to pathological level of amyloid β peptides.BMC Neurosci. 2012 Dec 29;13:155. doi: 10.1186/1471-2202-13-155. BMC Neurosci. 2012. PMID: 23272676 Free PMC article.
-
Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.Neurol Res. 2019 Feb;41(2):139-150. doi: 10.1080/01616412.2018.1544745. Epub 2018 Nov 19. Neurol Res. 2019. PMID: 30453864
-
A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides.J Neurosci. 2009 Jan 28;29(4):918-29. doi: 10.1523/JNEUROSCI.3952-08.2009. J Neurosci. 2009. PMID: 19176801 Free PMC article.
-
Neuroprotective and Neurotoxic Implications of α7 Nicotinic Acetylcholine Receptor and Aβ Interaction: Therapeutic Options in Alzheimer's Disease.Curr Drug Targets. 2017;18(13):1537-1544. doi: 10.2174/1389450117666161005145143. Curr Drug Targets. 2017. PMID: 27719660 Review.
-
On the interaction of β-amyloid peptides and α7-nicotinic acetylcholine receptors in Alzheimer's disease.Curr Alzheimer Res. 2013 Jul;10(6):618-30. doi: 10.2174/15672050113109990132. Curr Alzheimer Res. 2013. PMID: 23627750 Review.
Cited by
-
Muscarinic Receptors and Alzheimer's Disease: New Perspectives and Mechanisms.Curr Issues Mol Biol. 2024 Jul 2;46(7):6820-6835. doi: 10.3390/cimb46070407. Curr Issues Mol Biol. 2024. PMID: 39057049 Free PMC article. Review.
References
REFERENCES
-
- Andersen, N. D., Nielsen, B. E., Corradi, J., Tolosa, M. F., Feuerbach, D., Arias, H. R., & Bouzat, C. (2016). Exploring the positive allosteric modulation of human alpha7 nicotinic receptors from a single‐channel perspective. Neuropharmacology, 107, 189–200. https://doi.org/10.1016/j.neuropharm.2016.02.032
-
- Arora, K., Alfulaij, N., Higa, J. K., Panee, J., & Nichols, R. A. (2013). Impact of sustained exposure to β‐amyloid on calcium homeostasis and neuronal integrity in model nerve cell system expressing α4β2 nicotinic acetylcholine receptors. The Journal of Biological Chemistry, 288(16), 11175–11190. https://doi.org/10.1074/jbc.M113.453746
-
- Azam, L., Winzer‐Serhan, U., & Leslie, F. M. (2003). Co‐expression of α7 and β2 nicotinic acetylcholine receptor subunit mRNAs within rat brain cholinergic neurons. Neuroscience, 119(4), 965–977. https://doi.org/10.1016/s0306-4522(03)00220-3
-
- Castellani, R. J., Zhu, X., Lee, H. G., Moreira, P. I., Perry, G., & Smith, M. A. (2007). Neuropathology and treatment of Alzheimer disease: Did we lose the forest for the trees? Expert Review of Neurotherapeutics, 7(5), 473–485. https://doi.org/10.1586/14737175.7.5.473
-
- Chakrapani, S., Bailey, T. D., & Auerbach, A. (2004). Gating dynamics of the acetylcholine receptor extracellular domain. The Journal of General Physiology, 123(4), 341–356. https://doi.org/10.1085/jgp.200309004
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources